Epidemiology of Systemic Mycoses in the COVID-19 Pandemic
Review
[키워드] age
Antifungal treatment
aspergillosis
candidiasis
caused
Characteristics
clinical picture
clinical suspicion
Co-infection
Cochrane Library
conditions
COVID-19
demographic
Diagnosis
diagnostic
diagnostic methods
diagnostic test
disease
endemic mycosis
Epidemiology
etiological agent
Fatality rate
fungal
Immunosuppression
Infection
Inflammatory cytokine
LILACS
limitation
male
molecular
Most patient
Mucormycosis
Mycose
Mycosis
nine
occurred
overcome
pandemic
Patient
pneumocystosis
Prognosis
promote
reduction
Risk factors
SARS-CoV-2
subject
Symptom
systemic
systemic mycoses
T-cell
was performed
were used
[DOI] 10.3390/jof7070556 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/jof7070556 PMC 바로가기 [Article Type] Review